<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0032">
 <label>32</label>
 <element-citation publication-type="journal" id="sbref0027">
  <person-group person-group-type="author">
   <name>
    <surname>Phillips</surname>
    <given-names>A.N.</given-names>
   </name>
   <name>
    <surname>Venter</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Havlir</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study</article-title>
  <source>Lancet HIV</source>
  <volume>6</volume>
  <issue>2</issue>
  <year>2019</year>
  <fpage>e116</fpage>
  <lpage>e127</lpage>
  <pub-id pub-id-type="doi">10.1016/S2352-3018(18)30317-5</pub-id>
  <pub-id pub-id-type="pmid">30503325</pub-id>
 </element-citation>
</ref>
